![](https://images.squarespace-cdn.com/content/v1/655278d1bae4525035680852/1714648364239-4YRR7U3ZJP9J1UWGD7ED/GettyImages-927402888.jpg)
Your Depression & TMS Specialists in Lehi, Utah 84043
Proven, Alternative
Depression Treatments
NeuroWellness Services
TMS
Transcranial magnetic stimulation is a non-invasive treatment that stimulates and strengthens the mood centers of the brain.
Spravato
Spravato (esketamine) is an alternative, in-office medication that provides rapid relief from symptoms of depression.
IOP
A structured, comprehensive individual and group therapy regimen focused on treating trauma, depression, and anxiety.
Breaking News: TMS Now FDA-Cleared as
First-Line Treatment for Teens Age 15+
What is Transcranial Magnetic Stimulation (TMS)?
TMS utilizes MRI technology to stimulate specific mood centers of the brain. These areas display reduced activity in individuals with depression, anxiety, obsessive compulsive disorder (OCD) and/or post traumatic stress disorder (PTSD). TMS is like physical therapy for these areas through neuroplasticity, or the brain’s ability to create and strengthen neural pathways. TMS requires no drugs, no surgery, and no recovery time, so you can get right back to your daily life.
At NeuroWellness, we don’t believe in lost causes. We will show you new ways to treat depression and do the heavy lifting with insurance so you can focus on feeling better. We truly want to be your partner in finding effective solutions that fit your situation.
NeuroStar has performed over 5.9 million treatments in over 162,000 patients.
TMS is an effective drug-free depression treatment that works for you
Watch Kelly's Story about TMS
Other Services
Intensive Outpatient Program (IOP)
In addition to TMS, we offer other services to give our patients the best results possible. For those who aren’t satisfied with once-a-week therapy, we provide an Intensive Outpatient Program (IOP). These structured treatment plans are designed to provide support and care by addressing the specific needs of each patient. IOP also provides community and peer support through group therapy and shared experiences, allowing patients to connect with those facing similar challenges.
Learn About IOP
Spravato® (esketamine)
At NeuroWellness, we also provide nasal esketamine treatments that rapidly improves symptoms of depression. SPRAVATO is a FDA-approved medication option for depression added to your current treatment plan including an oral antidepressant. SPRAVATO® is nasal inhalation self-administered at our office under our healthcare providers supervision.
Learn About Spravato
Frequently Asked Questions
-
NeuroWellness Utah is dedicated to offering advanced mental health treatments like TMS to residents throughout Utah, with a special focus on communities around Lehi, including Salt Lake City, Provo, Sandy, and Draper. Our reach extends across the Wasatch Front and into the heart of Utah Valley, ensuring accessible, innovative care for individuals facing challenges with anxiety, depression, OCD, and PTSD. From the bustling streets of West Jordan to the quiet neighborhoods of American Fork, NeuroWellness is here to guide you on your path to mental well-being.
-
NeuroWellness specializes in cutting-edge, alternative mental health treatments designed to empower individuals seeking new paths to wellness. Our core services include Transcranial Magnetic Stimulation (TMS), Spravato treatment, and Intensive Outpatient Programs (IOP). We believe in bringing therapeutic and medical perspectives together to offer the most comprehensive approach to supporting our patients in their mental health and well-being journey.
-
Scheduling an appointment with NeuroWellness is easy and confidential. Simply visit our 'Contact Us' page and fill out the appointment request form with your details and preferences. Alternatively, you can call our clinic directly at (385) 352-7137 to speak with our friendly staff who can assist you in setting up your initial consultation.
We're here to guide you through every step of the process, ensuring a seamless start to your journey towards better mental health.
-
At NeuroWellness, we hold your privacy and confidentiality in the highest regard. All personal information shared with us, from your initial inquiry to your treatment details, is protected under strict privacy policies and complies with HIPAA regulations.
We employ robust security measures to ensure your data is secure and accessed only by authorized personnel involved in your care. Your trust is fundamental to our practice, and we are committed to safeguarding your information every step of the way.
-
Transcranial Magnetic Stimulation (TMS) is a non-invasive medical treatment that uses magnetic fields to stimulate nerve cells in the brain. It's specifically designed to target areas affected by mental health conditions, such as depression, anxiety, OCD and PTSD, when other treatments haven't been effective.
By applying focused magnetic impulses through the scalp, TMS encourages positive changes in the brain's neurotransmitter levels, offering relief from symptoms and improving overall mental health without the need for medication. FDA-cleared and clinically proven, TMS is a safe and effective alternative for those seeking new avenues to wellness.
-
TMS treatment is covered by many insurance plans, including Medicare, for patients who meet specific criteria, typically those diagnosed with depression that has not responded to traditional treatments. At NeuroWellness, we work closely with you to navigate the insurance process, providing assistance with pre-authorization and helping to clarify your coverage details.
We recommend contacting your insurance provider directly to confirm your eligibility for TMS coverage, and our staff is here to support you with any required documentation or information needed to facilitate this process.
-
TMS treatment is generally well-tolerated and does not involve pain. During the session, you may feel a tapping or clicking sensation on your scalp and hear a clicking sound as the device operates. Some patients report mild discomfort or a slight headache during or after the treatment, but these sensations typically diminish with subsequent sessions. Our skilled medical team at NeuroWellness ensures that each session is as comfortable as possible, adjusting treatment parameters to suit your sensitivity and comfort levels, making TMS a preferred option for many seeking relief from mental health conditions without the discomfort of invasive procedures
-
Transcranial Magnetic Stimulation (TMS) has been FDA-cleared as a safe and effective treatment option for individuals with depression. TMS is considered a safe treatment during pregnancy, and the non-invasive nature of TMS makes it a desirable option for some, offering relief from depression symptoms without the systemic side effects associated with pharmaceutical treatments.
Every pregnancy is unique, and the decision to undergo TMS treatment should be made in consultation with your healthcare provider, taking into account your specific health circumstances and treatment history. At NeuroWellness, our team is dedicated to providing comprehensive care, guiding you through a personalized treatment plan to ensure the best outcomes for both you and your baby.
“After these treatments, I feel like I'm more connected with myself and the world around me, and I can truly say that I'm happy with myself.”
— Benjamin
TESTIMONIALS
![](https://images.squarespace-cdn.com/content/v1/655278d1bae4525035680852/92258365-891d-46a4-9e3a-583833479fb8/AdobeStock_422342732.png)
Schedule a discovery session for free and see if it’s right for you.
*The outcomes reported respresent the subset of study patients for which the CGI-S data were reported before and after an acute course of NeuroStar TMS. Patients were treated under real-world conditions where they may have been prescribed concomitant depression treatments including medications. “Improvement in depression symptoms” was defined as a CGI-S score <3 and “symptom relief (remission)” was defined as a CGI-S score <2 at the end of treatment.
1. Post A, Keck ME. J Psychiatr Res. 2001;35(4):193-215.